We are live on ! Find out more
OAM

Oppenheimer Asset Management Portfolio holdings

AUM $9.63B
1-Year Est. Return 30.32%
This Fund
S&P 500
This Quarter Est. Return
+9.4%
1 Year Est. Return
+30.32%
3 Year Est. Return
+85%
5 Year Est. Return
+99.62%
10 Year Est. Return
+601.29%
AUM
$6.83B
AUM Growth
-$363M
Cap. Flow
-$888M
Cap. Flow %
-13.01%
Top 10 Hldgs %
18.06%
Holding
1,191
New
52
Increased
233
Reduced
823
Closed
83

Sector Composition

Rank Sector Weight
1 Technology 20.15%
2 Financials 13.7%
3 Healthcare 12.96%
4 Consumer Discretionary 11.08%
5 Industrials 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FAF icon
951
First American
FAF
$7.44B
$311K ﹤0.01%
5,099
-985
-16% -$58.2K
DNUT icon
952
Krispy Kreme
DNUT
$555M
$310K ﹤0.01%
20,365
-2,775
-12% -$37K
GGG icon
953
Graco
GGG
$13.4B
$310K ﹤0.01%
3,317
-266
-7% -$23.5K
BRZE icon
954
Braze
BRZE
$3.17B
$307K ﹤0.01%
6,938
+923
+15% +$49.8K
NOMD icon
955
Nomad Foods
NOMD
$1.64B
$305K ﹤0.01%
15,608
-2,786
-15% -$51.3K
E icon
956
ENI
E
$78.9B
$305K ﹤0.01%
9,600
-434
-4% -$13.8K
SHOO icon
957
Steven Madden
SHOO
$3.6B
$301K ﹤0.01%
7,128
-6,014
-46% -$254K
NEU icon
958
NewMarket
NEU
$8.27B
$301K ﹤0.01%
474
-14
-3% -$8.39K
HST icon
959
Host Hotels & Resorts
HST
$15.5B
$298K ﹤0.01%
14,396
-1,375
-9% -$27.6K
VVX icon
960
V2X
VVX
$2.64B
$297K ﹤0.01%
6,369
-2,754
-30% -$113K
RARE icon
961
Ultragenyx Pharmaceutical
RARE
$2.56B
$295K ﹤0.01%
6,319
+20
+0.3% +$943
PNTG icon
962
Pennant Group
PNTG
$1.37B
$293K ﹤0.01%
14,937
-1,112
-7% -$18.7K
SNN icon
963
Smith & Nephew
SNN
$12.5B
$293K ﹤0.01%
11,555
-409
-3% -$11.2K
AMX icon
964
America Movil
AMX
$71.1B
$293K ﹤0.01%
+15,682
New +$289K
DGX icon
965
Quest Diagnostics
DGX
$26.2B
$292K ﹤0.01%
2,193
-97
-4% -$12.6K
EG icon
966
Everest Group
EG
$14.2B
$290K ﹤0.01%
730
-1,464
-67% -$549K
YUMC icon
967
Yum China
YUMC
$16.4B
$284K ﹤0.01%
7,131
-2,430
-25% -$95.9K
VMD icon
968
Viemed Healthcare
VMD
$361M
$282K ﹤0.01%
29,927
+850
+3% +$7.29K
TIPT icon
969
Tiptree Inc
TIPT
$672M
$281K ﹤0.01%
16,252
+1,473
+10% +$26.4K
SNEX icon
970
StoneX
SNEX
$7.8B
$281K ﹤0.01%
13,476
-399
-3% -$7.99K
SPYV icon
971
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.5B
$280K ﹤0.01%
5,589
-1,914
-26% -$91.3K
NARI
972
DELISTED
Inari Medical, Inc. Common Stock
NARI
$279K ﹤0.01%
5,820
-76
-1% -$4.06K
VST icon
973
Vistra
VST
$48.2B
$278K ﹤0.01%
3,995
-44,803
-92% -$2.22M
JXN icon
974
Jackson Financial
JXN
$9.01B
$278K ﹤0.01%
4,199
-929
-18% -$50.4K
LGTY
975
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$276K ﹤0.01%
24,071
+4,111
+21% +$46.3K

Similar funds

Oppenheimer Asset Management's Q1 2024 Portfolio in Review

As of Q1 2024, Oppenheimer Asset Management held 1,191 positions worth $6.83B, down 5.1% from $7.19B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer Asset Management withdrew a net $888M in Q1 2024, closing 83 positions and reducing 823 holdings. Its most notable exit was ALPS Equal Sector Weight ETF, an estimated $20.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Oppenheimer Asset Management opened a new position in Petrobras worth $4.39M.

  • Oppenheimer Asset Management's largest Q1 2024 buy was Petrobras: 288,798 shares worth $4.39M.
  • Oppenheimer Asset Management added most to Goldman Sachs Access Treasury 0-1 Year ETF in Q1 2024, an estimated $30.8M increase.
  • Oppenheimer Asset Management's biggest Q1 2024 reduction was Microsoft, cutting an estimated $45.9M.
  • Oppenheimer Asset Management fully exited ALPS Equal Sector Weight ETF in Q1 2024, selling an estimated $20.1M.
  • Oppenheimer Asset Management's ten largest holdings make up 18% of its $6.83B portfolio in Q1 2024.
  • Oppenheimer Asset Management opened 52 new positions and closed 83 in Q1 2024.
  • Oppenheimer Asset Management's portfolio value fell 5.1% quarter-over-quarter to $6.83B.

Based on Oppenheimer Asset Management's 13F filing for Q1 2024, filed 7 May 2024.